EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional and structural interactions of novel acrylamide-based compounds with the α7 nicotinic acetylcholine receptor

Han-Shen Tae, Marcelo O Ortells, Katarzyna M Targowska-Duda, Dina Manetti, Maria N Romanelli, David J Adams, Hugo R Arias

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2025.117463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Han-Shen Tae und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Horizons/Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia. Electronic address: hstae@uow.…. Hauptthemen laut MEDLINE: alpha7 Nicotinic Acetylcholine Receptor, Acrylamides, Acrylamide. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Florence, National Health and Medical Research Council, Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The primary objective of this study was to structurally and functionally characterize a series of novel acrylamide-based compounds at the rat α7 nicotinic acetylcholine receptor (nAChR). Electrophysiological analyses revealed that DM497 [(E)-3-(thiophen-2-yl)-N-(p-tolyl)acrylamide] exhibited dual activity: at low acetylcholine (ACh) concentrations, it potentiated the α7 nAChR by delaying desensitization, whereas at high concentrations, it inhibited receptor activity. In contrast, ERR91 [(E)-3-(benzofuran-2-yl)-N-(p-tolyl)acrylamide] displayed only potentiating effects. Several compounds exhibited purely inhibitory effects, with DM490 [(E)-3-(furan-2-yl)-N-methyl-N-(p-tolyl)acrylamide] and ERR6 [(E)-3-(furan-2-yl)-1-(isoindolin-2-yl)prop-2-en-1-one] identified as the most potent negative allosteric modulators (NAMs). The activity of both NAMs (e.g. DM490) and positive allosteric modulators (PAMs) (e.g. DM497) was voltage-independent, suggesting that these compounds do not interact directly with the ion channel pore. Notably, at higher agonist concentrations, DM497's PAM activity transitioned to NAM activity, while DM490's NAM activity was further enhanced, an effect inconsistent with steric interactions at the orthosteric site. Molecular docking simulations excluded luminal interactions but identified two distinct intersubunit binding sites for DM497 and PAM-4 [(E)-3-furan-2-yl-N-phenylacrylamide], corresponding to PAM activity. In contrast, two non-overlapping intrasubunit sites were identified for DM490, likely contributing to its NAM activity. Additionally, a unique intersubunit site for DM497 was observed, which may explain its NAM activity at high ACh concentrations. The distinct binding locations of DM497 and DM490 align with functional competition assays, indicating that these compounds bind to different sites. Together, these findings suggest that the determination of PAM versus NAM activity may depend on selective interactions with intersubunit versus intrasubunit binding sites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha7 Nicotinic Acetylcholine ReceptorAcrylamidesAcrylamideAnimalsRatsStructure-Activity RelationshipMolecular Docking SimulationXenopus laevisAllosteric Regulation

Stichwörter der Autor:innen

Acrylamide-based compoundsElectrophysiologyMolecular dockingNegative allosteric modulatorNicotinic acetylcholine receptorPositive allosteric modulator

Substanzen

alpha7 Nicotinic Acetylcholine ReceptorAcrylamidesAcrylamide

Autor:innen und Institutionen

  • Molecular Horizons/Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia. Electronic address: hstae@uow.edu.au.
  • Facultad de Medicina (Universidad de Morón), Metavitalic SRL, and CONICET, Argentina.
  • Department of Biopharmacy, Medical University of Lublin, Lublin, Poland.
  • Department of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Italy.
  • Molecular Horizons/Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia.
  • Department of Pharmacology and Physiology, Oklahoma State University College of Osteopathic Medicine, Tahlequah, OK, USA.

Förderung

  • University of Florence
  • National Health and Medical Research Council
  • Medical University of Lublin

Zitieren

APA

Tae, H. S., Ortells, M. O., Targowska-Duda, K. M., Manetti, D., Romanelli, M. N., Adams, D. J., & Arias, H. R. (2026). Functional and structural interactions of novel acrylamide-based compounds with the α7 nicotinic acetylcholine receptor. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117463

Vancouver

Tae HS, Ortells MO, Targowska-Duda KM, Manetti D, Romanelli MN, Adams DJ, et al. Functional and structural interactions of novel acrylamide-based compounds with the α7 nicotinic acetylcholine receptor. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2025.117463

BibTeX
@article{Tae2026,
  author = {Tae, Han-Shen and Ortells, Marcelo O and Targowska-Duda, Katarzyna M and Manetti, Dina and Romanelli, Maria N and Adams, David J and Arias, Hugo R},
  title = {Functional and structural interactions of novel acrylamide-based compounds with the α7 nicotinic acetylcholine receptor},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2025.117463}
}
Kostenlos starten →